1881 - 1890 of 6466 Results
Title
Year
-
OPENTitle: Divergent Effects of G2019S and R1441C LRRK2 Mutations on LRRK2 and Rab10 Phosphorylations in Mouse TissuesJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 11Start Page: 2344End Page: 2344Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9112344Best OA location URL: https://www.mdpi.com/2073-4409/9/11/2344/pdf?version=1603442755Citation Count: 60
-
OPENTitle: Expression of suppressor of cytokine signaling genes in human elderly and Alzheimer’s disease brains and human microgliaJournal Name: NeurosciencePublisher: Elsevier BVVol: 302Issue #:Start Page: 121End Page: 137Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2014.09.052Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4385752Citation Count: 55
-
OPENTitle: Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease: a prospective cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 25Issue #: 4Start Page: 357End Page: 367Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00029-3Best OA location URL: https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(26)00029-3.pdfCitation Count: 4
-
OPENTitle: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotypeJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 30Issue #: 4Start Page: 1465End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021Best OA location URL: http://www.cell.com/article/S1525001622000211/pdfCitation Count: 25
- Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)2018OPENTitle: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 77Issue #: 9Start Page: 793End Page: 802Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nly056Best OA location URL: https://academic.oup.com/jnen/article-pdf/77/9/793/25507335/nly056.pdfCitation Count: 37
-
OPENTitle: Small Molecule Improvement of Trafficking Defects in Models of NeurodegenerationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 21Start Page: 3972End Page: 3984Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00524Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9754116Citation Count: 1
- Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial2025OPENTitle: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 12Start Page: 2688End Page: 2699Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70028Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70028Citation Count: 4
- Validation of a performance‐based assessment of cognitive functional ability in Parkinson's disease2018OPENTitle: Validation of a performance‐based assessment of cognitive functional ability in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1760End Page: 1768Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27487Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6261681Citation Count: 21
-
OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 161End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 100
-
OPENTitle: Accelerating Medicines Partnership® Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease ResearchJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 4Start Page: 972End Page: 980Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70183Citation Count: 0